Archive for June, 2006



FDA grants combination HIV drug approval for overseas useMarketWatch - 5 hours agoWASHINGTON (MarketWatch) — The US Food and Drug Administration said Friday it's granted the first tentative approval for a three-ingredient fixed dose tablet …..

FDA grants combination HIV drug approval for overseas useMarketWatch - 15 hours agoWASHINGTON (MarketWatch) — The US Food and Drug Administration said Friday it's granted the first tentative approval for a three-ingredient fixed dose tablet ….

The Food and Drug Administration approved a Genentech Inc. drug to treat a condition that’s a major cause of blindness in people over 55.

Shares of biotech drug maker Genentech Inc. closed higher Friday, after the Food and Drug Administration approved its age-related blindness treatment, Lucentis.

The Food and Drug Administration approved a Genentech Inc. drug to treat a condition that’s a major cause of blindness in people over 55.

The first tentative approval for a three-ingredient fixed dose tablet for use as a stand-alone antiretroviral treatment for human immunodeficiency virus (HIV-1) infection in adults.

Number of Macular Degeneration Cases Expected to Increases as Population Ages June 30, 2006 - At first, Gloria Cohen thought her failing vision was simply a result of nearing 40 and needing reading glasses.

Jun 30, 2006 - Teva Pharmaceutical Industries Ltd. announced today that the U.S. Food and Drug Administration has granted final approval for the Company’s Abbreviated New Drug Application to market its generic …

Lucentis is the first treatment which, when dosed monthly, can maintain the vision of more than 90 percent of patients with this type of AMD.

Compounded — also known as “bio-identical” — hormones are mixtures of estrogen and progesterone that are extracted from plants and usually customized for women by pharmacies based on the results of hormone …

The anemia drug Revlimid has been approved by the U.S. Food and Drug Administration for a new use to treat multiple myeloma, a cancer of the blood.

FDA approves Ranbaxy's drug to treat infectionsJacksonville Business Journal, FL - 8 hours agoThe Food and Drug Administration has given Ranbaxy Pharmaceuticals Inc. approval to manufacture and market a generic drug for treating … Ranb…

The first drug shown to significantly improve the vision of patients threatened by a major cause of blindness in the elderly won federal approval Friday.

WASHINGTON, June 30 /U.S. Newswire/ — The American Public Health Association (APHA) today recognizes the 100th anniversary of the passage of the Pure Food and Drugs Act of 1906, the founding law of the U.S. Food and Drug Administration.

The Food and Drug Administration approved a Genentech drug to treat a disease that’s a major cause of blindness in people over 55.




About

You are currently browsing the Regulatory Affairs Syndicator weblog archives for June, 2006.

Longer entries are truncated. Click the headline of an entry to read it in its entirety.

Categories